Join
Live feed
·
INSIDERFilingvia Quantisnow
Xeris Biopharma Holdings Inc. logo

Director Brady James Aloysius was granted 100,000 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
XERS· Xeris Biopharma Holdings Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track XERS (Xeris Biopharma Holdings Inc.) and more on Quantisnow.